← All trials
NCT04129060
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2019
- Primary completion
- Mar 31, 2024
- Completion date
- May 31, 2024
- First posted
- —
- Last posted
- —
- Enrollment
- 120
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of VermontLead sponsor
- University of VermontOverall official - principal investigator
- University of VermontReponsible party - principal investigator
- Vanderbilt UniversityCollaborator
- Vanderbilt UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.